Donating plasma is important because it provides the raw material for therapies that keep hundreds of thousands of people alive, from patients with immune deficiencies to burn victims in intensive care. Unlike whole blood, which can be used relatively quickly after collection, plasma is typically processed into specialized protein therapies that treat chronic and life-threatening conditions with no synthetic alternative. Global demand for these products has grown at roughly 7% per year over the past five years, and supply depends almost entirely on voluntary and paid donors.
What Plasma Actually Does in Your Body
Plasma is the pale yellow liquid that makes up about 55% of your blood volume. It carries red blood cells, white blood cells, and platelets throughout your circulatory system, but it also performs critical jobs on its own. The protein albumin, the most abundant protein in plasma, keeps fluid balanced between your blood vessels and surrounding tissues. Without enough albumin, fluid leaks into places it shouldn’t be, causing dangerous swelling.
Plasma also carries immune proteins called globulins that fight infections, assist with blood clotting, and transport nutrients. Think of plasma as both the highway and the cargo trucks of your bloodstream: it moves immune cells to sites of infection, delivers hormones and medications to their targets, and helps repair damaged tissue. When someone can’t produce these proteins on their own, the only option is to get them from donated human plasma.
Who Depends on Plasma Donations
The biggest category of patients relying on plasma are people with primary immunodeficiency disorders. These are genetic conditions where the immune system can’t produce enough protective antibodies. Patients receive regular infusions of immunoglobulin, a concentrated antibody product extracted from pooled plasma donations. It takes about 130 individual plasma donations to treat just one person with primary immunodeficiency for a single year. That number puts the scale of need into perspective: thousands of patients each require contributions from over a hundred donors annually.
People with alpha-1 antitrypsin deficiency, a genetic condition that damages the lungs and can cause emphysema, also rely on weekly infusions of a protective protein purified from donated plasma. These infusions, known as augmentation therapy, help slow lung damage that would otherwise progress steadily. For some patients, this treatment continues for life.
Burn and trauma victims represent another critical group. When someone suffers a major burn, albumin rapidly leaks out of damaged blood vessels, causing severe fluid imbalance and swelling. Replacing that albumin with plasma-derived products helps stabilize blood pressure and reduces the total volume of fluid doctors need to infuse during resuscitation. Clotting factors derived from plasma are also essential for people with hemophilia and other bleeding disorders who cannot form blood clots on their own.
Why Plasma Can’t Be Manufactured
Despite decades of biomedical research, the complex proteins in human plasma still cannot be synthesized in a lab at the scale or specificity needed for patient care. Immunoglobulin alone contains thousands of different antibodies reflecting the immune experience of the donor population. No manufacturing process can replicate that diversity. This means every vial of immunoglobulin, every bag of albumin, and every dose of clotting factor traces back to someone who sat in a donation chair.
The global immunoglobulin market reached nearly $19 billion in 2023 and has been growing at about 10% annually. Albumin holds the second-largest share at roughly $6 billion. These numbers reflect real patient demand that keeps climbing as populations age, diagnostic capabilities improve in developing countries, and more conditions are identified as treatable with plasma-derived therapies.
How Plasma Donation Differs From Blood Donation
Standard whole blood donation collects about 450 milliliters of blood, which is then separated into components including plasma. But the yield of usable plasma from a whole blood donation is relatively small. Plasma donation uses a process called apheresis, where a machine draws your blood, separates out the plasma, and returns your red blood cells and platelets back to you. This produces a considerably greater volume of plasma per session and is easier on your body since you keep the cellular components that take longest to replace.
Your body replaces the donated plasma volume within about 24 hours, which is why the FDA allows source plasma donations up to twice per week, with at least 48 hours between sessions. This is far more frequent than whole blood donation, which is limited to once every eight weeks. That higher frequency is part of what makes the plasma supply chain viable, since each patient’s annual treatment requires so many individual donations.
The Ongoing Supply Challenge
Demand for plasma-derived products continues to outpace collection. As global use grows and new patient populations gain access to treatment, collection centers need a steady and expanding base of donors. The United States currently supplies the majority of the world’s source plasma, partly because it is one of the few countries that compensates donors for their time. Many countries in Europe and elsewhere restrict paid donation, which limits collection volumes.
Seasonal dips, public health events, and donor fatigue all create fluctuations in supply. Because plasma-derived medications take months to manufacture (the plasma must be tested, pooled, fractionated into components, and quality-checked), a shortfall in donations today doesn’t show up as a treatment shortage for six to twelve months. By the time patients feel the impact, it’s too late to fix quickly. Consistent, repeat donors are the backbone of the entire system, and losing even a fraction of them creates ripple effects across hospitals and specialty pharmacies worldwide.
What the Experience Looks Like
A plasma donation appointment typically takes 60 to 90 minutes, longer than a standard blood draw because of the apheresis process. You’ll sit in a reclining chair while the machine cycles your blood through a few draw-and-return cycles. Most people describe a mild tingling sensation from the anticoagulant used during the process, but serious side effects are uncommon. Staying well-hydrated before and after your appointment helps your body restore its plasma volume quickly.
Because your red blood cells are returned to you, the fatigue that sometimes follows whole blood donation is generally less pronounced. Most donors feel normal within a few hours. The protein levels in your plasma take a bit longer to fully rebuild, which is one reason for the 48-hour minimum between donations. Regular donors often settle into a routine of donating once or twice a week without significant disruption to their daily lives.